Tekla Healthcare Investors (HQH)

$19.88

up-down-arrow $0.23 (1.17%)

As on 29-May-2026 11:46EDT

Market cap

info icon

$1,114 Mln

Revenue (TTM)

info icon

$19 Mln

P/E Ratio

info icon

12.1

P/B Ratio

info icon

1

Div. Yield

info icon

11.4 %

Tekla Healthcare Investors (HQH) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 19.71 High: 19.92

52 Week Range

Low: 15.09 High: 20.46

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    0.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    0

  • Debt to EquityDebt to Equity information

    --

  • Book ValueBook Value information

    $20

  • EPSEPS information

    $1.8

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    57,192,236

10 Years Aggregate

CFO

$-141.08 Mln

EBITDA

$611.16 Mln

Net Profit

$565.84 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Tekla Healthcare Investors (HQH)
5.0 1.4 3.8 30.7 6.1 -4.1 -2.5
BSE Sensex
-11.7 -2.7 -8.0 -8.0 6.2 7.8 10.9
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 29-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Tekla Healthcare Investors (HQH)
18.0 -3.1 -7.9 -24.2 -0.3 14.1 16.3
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Tekla Healthcare Investors (HQH)
19.9 1,113.5 99.8 98.6 527.8 9.2 12.1 1.0
15.9 1,626.1 225.0 222.0 -- 13.4 7.3 1.0
30.4 1,973.0 266.0 314.4 -- 20.3 6.2 1.1
10.9 3,019.1 599.0 -550.0 -0.5 -9.6 -- 0.6
64.2 1,542.3 163.9 339.8 27.3 20.6 4.4 1.0
13.6 2,396.5 -42.2 -46.9 60.8 -1.9 -- 1.0
16.8 1,256.3 325.8 321.3 -- 25.6 3.9 0.9
2.4 1,142.3 99.4 -37.8 -83.0 -1 -- 0.4
17.4 1,708.9 101.9 174.1 -- 8 9.8 0.8
35.3 1,855.7 204.6 254.3 -- 13.1 7.1 1.0

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Tekla Healthcare Investors (HQH)

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the...  biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Address: 1900 Market Street, Philadelphia, PA, United States, 19103  Read more

  • Portfolio Manager

    Dr. Daniel R. Omstead M.S, Ph.D.

  • Portfolio Manager

    Dr. Daniel R. Omstead M.S, Ph.D.

  • Headquarters

    Philadelphia, PA

  • Website

    https://www.teklacap.com/hqh.html

Edit peer-selector-edit
loading...
loading...

FAQs for Tekla Healthcare Investors (HQH)

The share price of Tekla Healthcare Investors (HQH) is $19.88 (NYSE) as of 29-May-2026 11:46 EDT. Tekla Healthcare Investors (HQH) has given a return of 6.07% in the last 3 years.

The P/E ratio of Tekla Healthcare Investors (HQH) is 12.09 times as on 22-May-2026.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
10.26
0.92
2024
5.40
0.94
2023
13.65
0.83
2022
-4.21
0.89
2021
7.49
1.00

The 52-week high and low of Tekla Healthcare Investors (HQH) are Rs 20.46 and Rs 15.09 as of 29-May-2026.

Tekla Healthcare Investors (HQH) has a market capitalisation of $ 1,114 Mln as on 22-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Tekla Healthcare Investors (HQH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.